Vote Scores
Filings read through

Verve Therapeutics, Inc.: how funds voted at the meeting of 6 Jun 2024

Meeting
Season
year to 30 June 2024
Filers reporting
283
Ballot items
4

283 filers on Form N-PX reported votes at the Verve Therapeutics, Inc. meeting of 6 Jun 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Verve Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 63.2% of the reported votes are for. 60 filers withheld from or voted against at least one nominee.

    362 vote records from 99 filers. 4 of the 97 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 34 fund families
    • For 11
    • Abstain or withhold 3
    • Split or no vote 20
    • Against management 2
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    395 vote records from 279 filers. 80 of the 264 filers that marked the item voted against management. 15 filers gave no management mark.

    • Positions of 41 fund families
    • For 27
    • Against 13
    • Split or no vote 1
    • Against management 13
  3. Item 3: Frequency of the say-on-pay vote

    One year: 244 filers. Three years: 5 filers. For: 4 filers. : 3 filers. 1-yr: 1 filer. Abstain: 1 filer.

    389 vote records from 272 filers. 7 of the 256 filers that marked the item voted against management. 16 filers gave no management mark.

    • Positions of 41 fund families
    • Split or no vote 41
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    181 vote records from 98 filers. 0 of the 96 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 34 fund families
    • For 33
    • Split or no vote 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Verve Therapeutics, Inc., meeting of 6 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinForSplitNo report
American BeaconForSplitFor
American CenturyAgainst, against managementSplitFor
BlackRock and iSharesAgainst, against managementSplitFor
BNY MellonForSplitNo report
Brighthouse FundsForSplitFor
Charles SchwabForSplitFor
Columbia ThreadneedleForSplitFor
DimensionalAgainst, against managementSplit, against managementFor
DWSForSplitFor
EquitableForSplitFor
Federated HermesForSplitFor
FidelityForSplitFor
Franklin TempletonForSplitNo report
Global XAgainst, against managementSplitFor
Goldman SachsForSplitFor
Guggenheim and RydexForSplitFor
Harbor FundsForSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganForSplitFor
Jackson National fundsAgainst, against managementSplit, against managementFor
Janus HendersonForSplitNo report
John Hancock and ManulifeForSplitFor
Lincoln FinancialForSplitFor
MassMutualSplitSplitSplit
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideAgainst, against managementSplitFor
Natixis and Loomis SaylesAgainst, against managementSplitNo report
Neuberger BermanAgainst, against managementSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsAgainst, against managementSplitFor
PGIM and PrudentialAgainst, against managementSplitNo report
PrincipalForSplitFor
ProShares and ProFundsForSplitFor
SEIAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
VoyaForSplitFor

Questions

How many filers reported votes at the Verve Therapeutics, Inc. meeting?
283 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 80 of 264 filers that marked the item voted against management (30.3%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Verve Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Verve Therapeutics, Inc. with a meeting date within three days of 6 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .